1. Home
  2. SNCR vs AFMD Comparison

SNCR vs AFMD Comparison

Compare SNCR & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • AFMD
  • Stock Information
  • Founded
  • SNCR 2000
  • AFMD 2000
  • Country
  • SNCR United States
  • AFMD Germany
  • Employees
  • SNCR N/A
  • AFMD N/A
  • Industry
  • SNCR EDP Services
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • AFMD Health Care
  • Exchange
  • SNCR Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • SNCR 137.5M
  • AFMD 53.3M
  • IPO Year
  • SNCR 2006
  • AFMD 2014
  • Fundamental
  • Price
  • SNCR $11.25
  • AFMD $3.36
  • Analyst Decision
  • SNCR
  • AFMD Strong Buy
  • Analyst Count
  • SNCR 0
  • AFMD 5
  • Target Price
  • SNCR N/A
  • AFMD $16.25
  • AVG Volume (30 Days)
  • SNCR 81.2K
  • AFMD 80.0K
  • Earning Date
  • SNCR 11-12-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • SNCR N/A
  • AFMD N/A
  • EPS Growth
  • SNCR N/A
  • AFMD N/A
  • EPS
  • SNCR N/A
  • AFMD N/A
  • Revenue
  • SNCR $167,615,000.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • SNCR $7.76
  • AFMD N/A
  • Revenue Next Year
  • SNCR $5.83
  • AFMD $48.98
  • P/E Ratio
  • SNCR N/A
  • AFMD N/A
  • Revenue Growth
  • SNCR 33.39
  • AFMD N/A
  • 52 Week Low
  • SNCR $2.70
  • AFMD $2.92
  • 52 Week High
  • SNCR $15.46
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 43.11
  • AFMD 44.84
  • Support Level
  • SNCR $10.45
  • AFMD $3.28
  • Resistance Level
  • SNCR $11.44
  • AFMD $3.51
  • Average True Range (ATR)
  • SNCR 0.57
  • AFMD 0.17
  • MACD
  • SNCR -0.06
  • AFMD 0.04
  • Stochastic Oscillator
  • SNCR 31.58
  • AFMD 55.79

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: